Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Jörg Latus, MD
Unveiling the Latest Advancements in CKD-Associated Pruritus Care
Stefan H. Jacobson, MD, PhD
Carlos Narváez Mejía, MD
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Can We Do Better in IgAN?
Annette Bruchfeld, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
Case-Based Management of AAV
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.